UTMB researchers were able to use another mosquito-borne virus that had remained largely unknown and unstudied in UTMB’s World Reference Center for Arboviruses, led by UTMB Professor Robert Tesh, to create the new test that could help doctors and researchers diagnose and track the spread of chikungunya.
The formerly unknown virus, now named Eilat virus, is related to chikungunya and other mosquito-borne viruses and was collected in Israel’s Negev Desert about three decades ago, said Scott Weaver, director of the Institute for Human Infections and Immunity at UTMB.
What researchers found is that they could replace the structural proteins of the Eilat virus with those of chikungunya and create a virus that looks like chikungunya to the immune system but will not replicate in humans, said Jesse Erasmus, a graduate student at UTMB who helped to develop the new test.
Most diagnostics available today use chikungunya virus that has been inactivated.
Health care professionals are able to take the serum of those suspected of being infected with chikungunya and, using the diagnostic test kit created in conjunction with InBios, have a result in less than two hours, Weaver said.
The development of a diagnostic kit for chikungunya virus is a classic example of a University-Industry partnership resulting in products which will improve the quality of life for at-risk patients.
“End users have provided positive feedback on the high quality of the kits and consistency of results.” Weaver said he believed the diagnostic kit could be of great help as chikungunya continues to spread. “If you have a kit that is simple to use and is more affordable, then more local hospitals and clinics can start using it rather than guessing whether someone has chikungunya,” Weaver said.
Read more: UTMB researchers help discover simple, affordable diagnostic kit for chikungunya
The Latest on: Chikungunya
[google_news title=”” keyword=”chikungunya” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Chikungunya
- Health team destroys larvae in Sunder Nagaron April 26, 2024 at 8:58 pm
With the onset of summer season, the number of patients of vector- borne diseases like malaria, dengue and chikungunya start increasing. Keep this ...
- Cases of infectious diseases likely to surge in Dharwad districton April 26, 2024 at 3:41 pm
Hubballi: As the temperature rises day by day in summer, the number of cases of infectious diseases is increasing.
- Rapid and Real-time Assays for Detection and Quantification of Chikungunya Viruson April 23, 2024 at 5:00 pm
A definitive diagnosis of Chikungunya infection can be made only with the aid of laboratory support since clinically, symptoms resemble those of dengue fever. Laboratory diagnosis is therefore ...
- Tag: Chikungunyaon April 19, 2024 at 9:09 am
A new clinical study shows promising results of a Phase III chikungunya vaccine trial, the first time the shot has been tested in humans. If approved by regulators, the vaccine would have the ...
- Chikungunya Newson April 18, 2024 at 5:00 pm
The findings could lead to a universal therapy or vaccine for the ... Dec. 2, 2021 — Dengue, Chikungunya, and Zika viruses have all been recorded in Mexico; however, recent diagnostic advances ...
- After coming up short in COVID, Valneva focuses on chikungunya vaccine launchon April 18, 2024 at 9:02 am
Thomas Lingelbach, CEO of French vaccine specialist Valneva, said that the company is focused on launching its newly approved shot for the chikungunya virus and on developing a second-generation ...
- Emergence and Clinical Insights into the Pathology of Chikungunya Virus Infectionon April 14, 2024 at 5:00 pm
Expert Rev Anti Infect Ther. 2010;8(9):987-996. Chikungunya, a tropical disease in poorer countries, is now becoming a major global health issue given the worldwide distribution of its mosquito ...
- First vaccine for chikungunya virus, an 'emerging global health threat,' gets FDA approvalon November 11, 2023 at 11:59 am
The U.S. Food and Drug Administration (FDA) on Thursday announced its approval of Ixchiq, the first chikungunya vaccine. The vaccine, which is made by Valneva, is approved for anyone age 18 and ...
- US approves world's first chikungunya vaccineon November 10, 2023 at 12:06 am
The US Food and Drug Administration has approved the world's first vaccine for chikungunya, which it sees as an "emerging global health threat". The mosquito-borne disease causes fever and joint ...
- Chikungunya News and Researchon November 8, 2023 at 4:00 pm
The chikungunya virus, transmitted by Aedes aegypti and Aedes albopictus mosquitoes and responsible for more than 900 deaths in Brazil since it arrived around ten years ago, is capable of ...
via Bing News